Down Syndrome clinical trials at UCSD
2 in progress, 2 open to new patients
open to eligible people ages 25-45
The purpose of this study is to test in adults with Down Syndrome the safety, tolerability and immunogenicity of a vaccine, ACI-24.
La Jolla, California and other locations
open to eligible females ages 18 years and up
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
San Diego, California and other locations